Docket Room
HB 1133·MD·house

Public Health - Drug Manufacturer-Funded Disease Awareness Campaigns - Registration and Required Disclosure

In CommitteeFiled Feb 11, 2026
Sponsor: Taveras
Latest Action

In the House - Hearing 3/12 at 1:00 p.m.

Mar 12, 2026

Summary

The bill forces drug manufacturers and any patient advocacy organization that receives their funding to file a registration with the Maryland Department of Health before launching a disease‑awareness effort. Campaign materials must clearly state the specific drug or device being marketed for the condition featured. This aims to increase transparency for the public about commercial influences behind health information.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 1133 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice